Company news
Canntab Therapeutics Limited news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
CSE Bulletin: Delist - Canntab Therapeutics Limited (PILL)
June 14, 2024
Canntab Therapeutics Limited Provides Update on Application for Management Cease Trade Order
September 18, 2023
Canntab Announces Corporate Update
November 22, 2022
Canntab announces its entrance into the nova scotia Cannabis market
August 22, 2022
Canntab announces appointment of Richard Goldstein as interim CEO
August 2, 2022
Canntab Corporate Update
June 30, 2022
Canntab announces change of auditor
May 30, 2022
Canntab Engages Hamish Sutherland as Strategic Advisor
April 13, 2022
Canntab signs affiliate agrrement with OnPharm-United
March 23, 2022
Canntab signs historic agreement with First Nations growers GP inc. to address the opiate and illicit drug crisis affecting Indigenous Peoples throughout Canada
February 7, 2022
Canntab announces closing of convertible debenture private placement, warrant expiry extension and corporate update
February 1, 2022
Canntab officially launches its online E-Commerce platform
January 20, 2022
CANNTAB DELIVERS 1st SHIPMENT TO THE ONTARIO CANNABIS STORE AND 2nd SHIPMENT TO AUSTRALIA
January 10, 2022
Canntab enters into strategic partnership to provide alternatives to opiates through levitee clinics
December 16, 2021
Canntab Receives Medical Sales Licence from Health Canada
November 11, 2021
Canntab Reaches Agreement with Innovative Bioinformatics Company, 36eight Technologies Inc.
October 18, 2021
Canntab Announces the Early Exercise of $1,259,250 Warrants
June 3, 2021
Canntab Mourns the Loss of Co-Founder
May 25, 2021
Canntab Receives Export License Approval from Health Canada
March 30, 2021
Canntab Granted 3rd Patent and Receives $400K Purchase Order in Australia
March 9, 2021
Canntab Fulfills 80% of Its Contract with MediPharm Labs Corp.
March 3, 2021
Canntab Engages Independent Trading Group for Market Making Services
February 17, 2021
Canntab Grants Options
February 3, 2021
Canntab Granted 2nd Patent For Immediate Release Cannabidiol Formulation Tablets
February 1, 2021
Canntab Announces Closing of Convertible Debenture Private Placement
December 31, 2020
Canntab Begins Delivery of Tablets to MediPharm
December 1, 2020
Canntab Therapeutics Announces End of Supply and Distribution Agreements with Exactus
November 16, 2020
Canntab to Launch in Australia and Participate in Australia's Largest Cannabis Research Study
October 26, 2020
Canntab Announces Closing of Purchases of Cannabis Processing Equipment and Leasehold Improvements
October 19, 2020
Canntab Granted 1st US Patent Covering Multi-Layer (Bi-Layer) Tablets
September 21, 2020
Canntab announces planned purchases of cannabis processing equipment and leasehold improvements
August 21, 2020
Canntab Appoints Larry Latowsky as CEO
August 19, 2020
Canntab and Medipharm Labs Enter Into a Wholesale Tablet Purchase Agreement
June 2, 2020
Canntab Appoints Joshi Laxminarayan as Chief Scientific Officer
May 15, 2020
Canntab to Present at the Canaccord Genuity 2020 Virtual Cannabis Conference
May 11, 2020
Canntab Closes Final Tranche of Private Placement for Aggregate Proceeds of $3.7m
March 16, 2020
Canntab Announces Replacement of Advisor Warrants and Intention to Appoint Larry Latowsky as Director and Executive Chairman of the Board
March 6, 2020
Canntab Announces Cancellation of Options and Issuance of Warrants
March 3, 2020
InvestmentPitch Media Video Discusses Canntab's Receipt of its Cannabis Standard Processing and Sales for Medical Purposes Licence from Health Canada and Close of 1st Tranche of Private Placement - Video Available on Investmentpitch.com
March 3, 2020
Canntab Receives Health Canada Licence and Closes $3.08M Offering
March 2, 2020
InvestmentPitch Media Video Discusses Canntab's Receipt of Cannabis Research Licence from Health Canada - Video Available on Investmentpitch.com
February 25, 2020
Canntab Awarded Health Canada Cannabis Research Licence
February 24, 2020
Canntab Announces Non-Brokered Private Placement
February 6, 2020
Canntab Submits Site Evidence Package to Health Canada to Obtain LP Status
December 23, 2019
Canntab Achieves Key Milestone: Canntab Enters Into Supply & Distribution Agreements With Exactus for the Purchase of Hemp-Derived CBD Oil and the Distribution of Canntab's Hard Pill Formulations in the United States
November 20, 2019
Canntab to utilize the advanced BOSS extraction system from Word Class Extractions to further its own extraction capabilities
October 8, 2019
InvestmentPitch Media Video Discusses Canntab's Receipt of Initial Indication of Patentability for Immediate Release Cannabidiol Formulation - Video Available on Investmentpitch.com
August 16, 2019
Canntab Receives Initial Indication of Patentability for Immediate Release Cannabidiol Formulation
August 15, 2019
InvestmentPitch Media Video Discusses Canntab's Update of Significant Developments Including Hemp Cultivation and Gel Capsule Manufacturing - Video Available on Investmentpitch.com
August 1, 2019
Canntab provides corporate update
July 31, 2019
Decks
The 5 newest of 8 decks. Every deck is listed under its year.
- Investor Presentation (September 2022)
Investor deck · 14 slides · September 2022
- Investor Presentation (May 2022)
Investor deck · 15 slides · May 2022
- Investor Presentation (March 2022)
Investor deck · 7 slides · March 2022
- Investor Presentation (January 2022)
Investor deck · 15 slides · January 2022
- Investor Presentation (September 2021)
Investor deck · 15 slides · September 2021